The UK government has published its latest set of research papers outlining the future for science and technology and future issues and trends in other fields over the next fifty years.
Boosting innovation in the European Union may be a top political priority but heads of state and government from the 25 countries in the Union had little time for the topic at this week’s summit in Brussels.
In the highest value deal yet seen for a preclinical pipeline, GlaxoSmithKline plc swooped on Domantis Ltd, paying £230 million cash for the six-year-old UK Medical Research Council spin out.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.